Skip to content

Proscia

2 viewers · 30d

Total raised

$35.0M

1 filing since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $35.0M
ROUNDS
1
INVESTORS
21
FOUNDED
N/A
HQ
Philadelphia, PA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Proscia Inc. is an innovative software company specializing in digital and computational pathology solutions designed to modernize and expedite cancer diagnostics and research. By leveraging advanced technologies, Proscia empowers laboratories and medical professionals to enhance their pathology workflows and provide faster, more accurate diagnoses.

What sets it apart

Proscia stands out by integrating AI applications into its flagship software, offering uniquely tailored solutions that address the complexities of modern pathology.

Funding history

1 round
Equity+1Mar 4, 2025
Form D
+$35.0M$35.0M total

Latest SEC filings

via EDGAR · CIK 0001625007
Form D · Mar 4, 2025View on EDGAR

Products

1 tracked

Concentriq

Pathology Software

Concentriq is Proscia's flagship enterprise pathology platform that facilitates the digitization of pathology workflows. It provides robust features for viewing, managing, analyzing, and sharing digital pathology images, enhancing the efficiency and accuracy of pathology processes.

  • Supports full digitization of clinical pathology workflows
  • Offers AI applications to assist pathologists
  • Provides a scalable platform suitable for various applications
  • Enables streamlined collaboration among pathologists and researchers

Links

WebsiteSEC EDGAR filings